Apple, Xeris and Zeta Hit 52-Week Highs on Earnings and Analyst Upgrades
Shares of Apple, Xeris Biopharma and Zeta Global reached 52-week highs on Wednesday after strong results and analyst price target increases, per Stocktwits.
- published on Newsmetry
- original source published
the same feed is available to bots and dashboards through the api. connect the api →
what happened
Shares of Apple, Xeris Biopharma and Zeta Global reached 52-week highs on Wednesday, according to Stocktwits. Solid quarterly results and a wave of analyst upgrades supported the stocks.
Apple (AAPL) rose to $355.91, lifting its market value above $5 trillion. Investors cited demand for the foldable iPhone Duo and a shift away from heavy AI capital spending. China Renaissance upgraded the stock to Buy from Hold with a $425 price target.
Xeris Biopharma (XERS) climbed to $16.57 and Zeta Global (ZETA) to $38.46. Barclays lifted its XERS target to $18, while Zeta's 46% revenue jump to $492.7 million led Morgan Stanley and Truist to raise their targets as well.
why it matters
The simultaneous gains reflect investor appetite for strong earnings and rising analyst optimism. For Apple, a post-election rotation from AI stocks into traditional tech names also played a role. Further moves will depend on upcoming quarterly data and how the market reacts to new forecasts.
market impact
Apple, Xeris, Zeta shares: strong results and upgrades support the stocks
tags
instruments
on polymarket
sources
- Why Did AAPL, XERS, ZETA Stocks Jump To 52-Week Highs Today? — Stocktwits, 12 November 2026 at 03:49 UTC
prepared by the newsmetry newsroom with ai assistance from the sources listed below. not investment advice.
alerts on your topics, the morning digest and the api — in your account.
get stories in real time ↗